Click for best price
Diabetic Retinopathy Drugs Market Size, Share 2022
Diabetic retinopathy is an ophthalmic disorder, in which blindness occurrs due to complications in diabetes.
This report contains market size and forecasts of Diabetic Retinopathy Drugs in global, including the following market information:
Global Diabetic Retinopathy Drugs Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Diabetic Retinopathy Drugs Market Sales, 2017-2022, 2023-2028, (K MT)
Global top five Diabetic Retinopathy Drugs companies in 2021 (%)
The global Diabetic Retinopathy Drugs market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Lucentis Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Diabetic Retinopathy Drugs include Novartis, Bayer Healthcare, Roche, Neurotech Pharmaceuticals, Regeneron Pharmaceuticals and Allergan, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Diabetic Retinopathy Drugs manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Diabetic Retinopathy Drugs Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K MT)
Global Diabetic Retinopathy Drugs Market Segment Percentages, by Type, 2021 (%)
Lucentis
Optina
Iluvien
Betamethazone
Ozurdex
Others
Global Diabetic Retinopathy Drugs Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K MT)
Global Diabetic Retinopathy Drugs Market Segment Percentages, by Application, 2021 (%)
50-60 Years Old
60-70 Years Old
Others
Global Diabetic Retinopathy Drugs Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K MT)
Global Diabetic Retinopathy Drugs Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Diabetic Retinopathy Drugs revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Diabetic Retinopathy Drugs revenues share in global market, 2021 (%)
Key companies Diabetic Retinopathy Drugs sales in global market, 2017-2022 (Estimated), (K MT)
Key companies Diabetic Retinopathy Drugs sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Novartis
Bayer Healthcare
Roche
Neurotech Pharmaceuticals
Regeneron Pharmaceuticals
Allergan
| Report Attributes |
Report Details |
| Report Title |
Diabetic Retinopathy Drugs Market - Global Outlook and Forecast 2022-2028 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2021 |
| Forecast Year |
2029 |
| Number of Pages |
71 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Diabetic Retinopathy Drugs Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Diabetic Retinopathy Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Diabetic Retinopathy Drugs Overall Market Size
2.1 Global Diabetic Retinopathy Drugs Market Size: 2021 VS 2028
2.2 Global Diabetic Retinopathy Drugs Revenue, Prospects & Forecasts: 2017-2028
2.3 Global Diabetic Retinopathy Drugs Sales: 2017-2028
3 Company Landscape
3.1 Top Diabetic Retinopathy Drugs Players in Global Market
3.2 Top Global Diabetic Retinopathy Drugs Companies Ranked by Revenue
3.3 Global Diabetic Retinopathy Drugs Revenue by Companies
3.4 Global Diabetic Retinopathy Drugs Sales by Companies
3.5 Global Diabetic Retinopathy Drugs Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 Diabetic Retinopathy Drugs Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers Diabetic Retinopathy Drugs Product Type
3.8 Tier 1, Tier 2 and Tier 3 Diabetic Retinopathy Drugs Players in Global Market
3.8.1 List of Global Tier 1 Diabetic Retinopathy Drugs Companies
3.8.2 List of Global Tier 2 and Tier 3 Diabetic Retinopathy Drugs Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Diabetic Retinopathy Drugs Market Size Markets, 2021 & 2028
4.1.2 Lucentis
4.1.3 Optina
4.1.4 Iluvien
4.1.5 Betamethazone
4.1.6 Ozurdex
4.1.7 Others
4.2 By Type - Global Diabetic Retinopathy Drugs Revenue & Forecasts
4.2.1 By Type - Global Diabetic Retinopathy Drugs Revenue, 2017-2022
4.2.2 By Type - Global Diabetic Retinopathy Drugs Revenue, 2023-2028
4.2.3 By Type - Global Diabetic Retinopathy Drugs Revenue Market Share, 2017-2028
4.3 By Type - Global Diabetic Retinopathy Drugs Sales & Forecasts
4.3.1 By Type - Global Diabetic Retinopathy Drugs Sales, 2017-2022
4.3.2 By Type - Global Diabetic Retinopathy Drugs Sales, 2023-2028
4.3.3 By Type - Global Diabetic Retinopathy Drugs Sales Market Share, 2017-2028
4.4 By Type - Global Diabetic Retinopathy Drugs Price (Manufacturers Selling Prices), 2017-2028
5 Sights By Application
5.1 Overview
5.1.1 By Application - Global Diabetic Retinopathy Drugs Market Size, 2021 & 2028
5.1.2 50-60 Years Old
5.1.3 60-70 Years Old
5.1.4 Others
5.2 By Application - Global Diabetic Retinopathy Drugs Revenue & Forecasts
5.2.1 By Application - Global Diabetic Retinopathy Drugs Revenue, 2017-2022
5.2.2 By Application - Global Diabetic Retinopathy Drugs Revenue, 2023-2028
5.2.3 By Application - Global Diabetic Retinopathy Drugs Revenue Market Share, 2017-2028
5.3 By Application - Global Diabetic Retinopathy Drugs Sales & Forecasts
5.3.1 By Application - Global Diabetic Retinopathy Drugs Sales, 2017-2022
5.3.2 By Application - Global Diabetic Retinopathy Drugs Sales, 2023-2028
5.3.3 By Application - Global Diabetic Retinopathy Drugs Sales Market Share, 2017-2028
5.4 By Application - Global Diabetic Retinopathy Drugs Price (Manufacturers Selling Prices), 2017-2028
6 Sights by Region
6.1 By Region - Global Diabetic Retinopathy Drugs Market Size, 2021 & 2028
6.2 By Region - Global Diabetic Retinopathy Drugs Revenue & Forecasts
6.2.1 By Region - Global Diabetic Retinopathy Drugs Revenue, 2017-2022
6.2.2 By Region - Global Diabetic Retinopathy Drugs Revenue, 2023-2028
6.2.3 By Region - Global Diabetic Retinopathy Drugs Revenue Market Share, 2017-2028
6.3 By Region - Global Diabetic Retinopathy Drugs Sales & Forecasts
6.3.1 By Region - Global Diabetic Retinopathy Drugs Sales, 2017-2022
6.3.2 By Region - Global Diabetic Retinopathy Drugs Sales, 2023-2028
6.3.3 By Region - Global Diabetic Retinopathy Drugs Sales Market Share, 2017-2028
6.4 North America
6.4.1 By Country - North America Diabetic Retinopathy Drugs Revenue, 2017-2028
6.4.2 By Country - North America Diabetic Retinopathy Drugs Sales, 2017-2028
6.4.3 US Diabetic Retinopathy Drugs Market Size, 2017-2028
6.4.4 Canada Diabetic Retinopathy Drugs Market Size, 2017-2028
6.4.5 Mexico Diabetic Retinopathy Drugs Market Size, 2017-2028
6.5 Europe
6.5.1 By Country - Europe Diabetic Retinopathy Drugs Revenue, 2017-2028
6.5.2 By Country - Europe Diabetic Retinopathy Drugs Sales, 2017-2028
6.5.3 Germany Diabetic Retinopathy Drugs Market Size, 2017-2028
6.5.4 France Diabetic Retinopathy Drugs Market Size, 2017-2028
6.5.5 U.K. Diabetic Retinopathy Drugs Market Size, 2017-2028
6.5.6 Italy Diabetic Retinopathy Drugs Market Size, 2017-2028
6.5.7 Russia Diabetic Retinopathy Drugs Market Size, 2017-2028
6.5.8 Nordic Countries Diabetic Retinopathy Drugs Market Size, 2017-2028
6.5.9 Benelux Diabetic Retinopathy Drugs Market Size, 2017-2028
6.6 Asia
6.6.1 By Region - Asia Diabetic Retinopathy Drugs Revenue, 2017-2028
6.6.2 By Region - Asia Diabetic Retinopathy Drugs Sales, 2017-2028
6.6.3 China Diabetic Retinopathy Drugs Market Size, 2017-2028
6.6.4 Japan Diabetic Retinopathy Drugs Market Size, 2017-2028
6.6.5 South Korea Diabetic Retinopathy Drugs Market Size, 2017-2028
6.6.6 Southeast Asia Diabetic Retinopathy Drugs Market Size, 2017-2028
6.6.7 India Diabetic Retinopathy Drugs Market Size, 2017-2028
6.7 South America
6.7.1 By Country - South America Diabetic Retinopathy Drugs Revenue, 2017-2028
6.7.2 By Country - South America Diabetic Retinopathy Drugs Sales, 2017-2028
6.7.3 Brazil Diabetic Retinopathy Drugs Market Size, 2017-2028
6.7.4 Argentina Diabetic Retinopathy Drugs Market Size, 2017-2028
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Diabetic Retinopathy Drugs Revenue, 2017-2028
6.8.2 By Country - Middle East & Africa Diabetic Retinopathy Drugs Sales, 2017-2028
6.8.3 Turkey Diabetic Retinopathy Drugs Market Size, 2017-2028
6.8.4 Israel Diabetic Retinopathy Drugs Market Size, 2017-2028
6.8.5 Saudi Arabia Diabetic Retinopathy Drugs Market Size, 2017-2028
6.8.6 UAE Diabetic Retinopathy Drugs Market Size, 2017-2028
7 Manufacturers & Brands Profiles
7.1 Novartis
7.1.1 Novartis Corporate Summary
7.1.2 Novartis Business Overview
7.1.3 Novartis Diabetic Retinopathy Drugs Major Product Offerings
7.1.4 Novartis Diabetic Retinopathy Drugs Sales and Revenue in Global (2017-2022)
7.1.5 Novartis Key News
7.2 Bayer Healthcare
7.2.1 Bayer Healthcare Corporate Summary
7.2.2 Bayer Healthcare Business Overview
7.2.3 Bayer Healthcare Diabetic Retinopathy Drugs Major Product Offerings
7.2.4 Bayer Healthcare Diabetic Retinopathy Drugs Sales and Revenue in Global (2017-2022)
7.2.5 Bayer Healthcare Key News
7.3 Roche
7.3.1 Roche Corporate Summary
7.3.2 Roche Business Overview
7.3.3 Roche Diabetic Retinopathy Drugs Major Product Offerings
7.3.4 Roche Diabetic Retinopathy Drugs Sales and Revenue in Global (2017-2022)
7.3.5 Roche Key News
7.4 Neurotech Pharmaceuticals
7.4.1 Neurotech Pharmaceuticals Corporate Summary
7.4.2 Neurotech Pharmaceuticals Business Overview
7.4.3 Neurotech Pharmaceuticals Diabetic Retinopathy Drugs Major Product Offerings
7.4.4 Neurotech Pharmaceuticals Diabetic Retinopathy Drugs Sales and Revenue in Global (2017-2022)
7.4.5 Neurotech Pharmaceuticals Key News
7.5 Regeneron Pharmaceuticals
7.5.1 Regeneron Pharmaceuticals Corporate Summary
7.5.2 Regeneron Pharmaceuticals Business Overview
7.5.3 Regeneron Pharmaceuticals Diabetic Retinopathy Drugs Major Product Offerings
7.5.4 Regeneron Pharmaceuticals Diabetic Retinopathy Drugs Sales and Revenue in Global (2017-2022)
7.5.5 Regeneron Pharmaceuticals Key News
7.6 Allergan
7.6.1 Allergan Corporate Summary
7.6.2 Allergan Business Overview
7.6.3 Allergan Diabetic Retinopathy Drugs Major Product Offerings
7.6.4 Allergan Diabetic Retinopathy Drugs Sales and Revenue in Global (2017-2022)
7.6.5 Allergan Key News
8 Global Diabetic Retinopathy Drugs Production Capacity, Analysis
8.1 Global Diabetic Retinopathy Drugs Production Capacity, 2017-2028
8.2 Diabetic Retinopathy Drugs Production Capacity of Key Manufacturers in Global Market
8.3 Global Diabetic Retinopathy Drugs Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Diabetic Retinopathy Drugs Supply Chain Analysis
10.1 Diabetic Retinopathy Drugs Industry Value Chain
10.2 Diabetic Retinopathy Drugs Upstream Market
10.3 Diabetic Retinopathy Drugs Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Diabetic Retinopathy Drugs Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Key Players of Diabetic Retinopathy Drugs in Global Market
Table 2. Top Diabetic Retinopathy Drugs Players in Global Market, Ranking by Revenue (2021)
Table 3. Global Diabetic Retinopathy Drugs Revenue by Companies, (US$, Mn), 2017-2022
Table 4. Global Diabetic Retinopathy Drugs Revenue Share by Companies, 2017-2022
Table 5. Global Diabetic Retinopathy Drugs Sales by Companies, (K MT), 2017-2022
Table 6. Global Diabetic Retinopathy Drugs Sales Share by Companies, 2017-2022
Table 7. Key Manufacturers Diabetic Retinopathy Drugs Price (2017-2022) & (USD/MT)
Table 8. Global Manufacturers Diabetic Retinopathy Drugs Product Type
Table 9. List of Global Tier 1 Diabetic Retinopathy Drugs Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Diabetic Retinopathy Drugs Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type ? Global Diabetic Retinopathy Drugs Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Global Diabetic Retinopathy Drugs Revenue (US$, Mn), 2017-2022
Table 13. By Type - Global Diabetic Retinopathy Drugs Revenue (US$, Mn), 2023-2028
Table 14. By Type - Global Diabetic Retinopathy Drugs Sales (K MT), 2017-2022
Table 15. By Type - Global Diabetic Retinopathy Drugs Sales (K MT), 2023-2028
Table 16. By Application ? Global Diabetic Retinopathy Drugs Revenue, (US$, Mn), 2021 & 2028
Table 17. By Application - Global Diabetic Retinopathy Drugs Revenue (US$, Mn), 2017-2022
Table 18. By Application - Global Diabetic Retinopathy Drugs Revenue (US$, Mn), 2023-2028
Table 19. By Application - Global Diabetic Retinopathy Drugs Sales (K MT), 2017-2022
Table 20. By Application - Global Diabetic Retinopathy Drugs Sales (K MT), 2023-2028
Table 21. By Region ? Global Diabetic Retinopathy Drugs Revenue, (US$, Mn), 2021 VS 2028
Table 22. By Region - Global Diabetic Retinopathy Drugs Revenue (US$, Mn), 2017-2022
Table 23. By Region - Global Diabetic Retinopathy Drugs Revenue (US$, Mn), 2023-2028
Table 24. By Region - Global Diabetic Retinopathy Drugs Sales (K MT), 2017-2022
Table 25. By Region - Global Diabetic Retinopathy Drugs Sales (K MT), 2023-2028
Table 26. By Country - North America Diabetic Retinopathy Drugs Revenue, (US$, Mn), 2017-2022
Table 27. By Country - North America Diabetic Retinopathy Drugs Revenue, (US$, Mn), 2023-2028
Table 28. By Country - North America Diabetic Retinopathy Drugs Sales, (K MT), 2017-2022
Table 29. By Country - North America Diabetic Retinopathy Drugs Sales, (K MT), 2023-2028
Table 30. By Country - Europe Diabetic Retinopathy Drugs Revenue, (US$, Mn), 2017-2022
Table 31. By Country - Europe Diabetic Retinopathy Drugs Revenue, (US$, Mn), 2023-2028
Table 32. By Country - Europe Diabetic Retinopathy Drugs Sales, (K MT), 2017-2022
Table 33. By Country - Europe Diabetic Retinopathy Drugs Sales, (K MT), 2023-2028
Table 34. By Region - Asia Diabetic Retinopathy Drugs Revenue, (US$, Mn), 2017-2022
Table 35. By Region - Asia Diabetic Retinopathy Drugs Revenue, (US$, Mn), 2023-2028
Table 36. By Region - Asia Diabetic Retinopathy Drugs Sales, (K MT), 2017-2022
Table 37. By Region - Asia Diabetic Retinopathy Drugs Sales, (K MT), 2023-2028
Table 38. By Country - South America Diabetic Retinopathy Drugs Revenue, (US$, Mn), 2017-2022
Table 39. By Country - South America Diabetic Retinopathy Drugs Revenue, (US$, Mn), 2023-2028
Table 40. By Country - South America Diabetic Retinopathy Drugs Sales, (K MT), 2017-2022
Table 41. By Country - South America Diabetic Retinopathy Drugs Sales, (K MT), 2023-2028
Table 42. By Country - Middle East & Africa Diabetic Retinopathy Drugs Revenue, (US$, Mn), 2017-2022
Table 43. By Country - Middle East & Africa Diabetic Retinopathy Drugs Revenue, (US$, Mn), 2023-2028
Table 44. By Country - Middle East & Africa Diabetic Retinopathy Drugs Sales, (K MT), 2017-2022
Table 45. By Country - Middle East & Africa Diabetic Retinopathy Drugs Sales, (K MT), 2023-2028
Table 46. Novartis Corporate Summary
Table 47. Novartis Diabetic Retinopathy Drugs Product Offerings
Table 48. Novartis Diabetic Retinopathy Drugs Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2017-2022)
Table 49. Bayer Healthcare Corporate Summary
Table 50. Bayer Healthcare Diabetic Retinopathy Drugs Product Offerings
Table 51. Bayer Healthcare Diabetic Retinopathy Drugs Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2017-2022)
Table 52. Roche Corporate Summary
Table 53. Roche Diabetic Retinopathy Drugs Product Offerings
Table 54. Roche Diabetic Retinopathy Drugs Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2017-2022)
Table 55. Neurotech Pharmaceuticals Corporate Summary
Table 56. Neurotech Pharmaceuticals Diabetic Retinopathy Drugs Product Offerings
Table 57. Neurotech Pharmaceuticals Diabetic Retinopathy Drugs Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2017-2022)
Table 58. Regeneron Pharmaceuticals Corporate Summary
Table 59. Regeneron Pharmaceuticals Diabetic Retinopathy Drugs Product Offerings
Table 60. Regeneron Pharmaceuticals Diabetic Retinopathy Drugs Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2017-2022)
Table 61. Allergan Corporate Summary
Table 62. Allergan Diabetic Retinopathy Drugs Product Offerings
Table 63. Allergan Diabetic Retinopathy Drugs Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2017-2022)
Table 64. Diabetic Retinopathy Drugs Production Capacity (K MT) of Key Manufacturers in Global Market, 2020-2022 (K MT)
Table 65. Global Diabetic Retinopathy Drugs Capacity Market Share of Key Manufacturers, 2020-2022
Table 66. Global Diabetic Retinopathy Drugs Production by Region, 2017-2022 (K MT)
Table 67. Global Diabetic Retinopathy Drugs Production by Region, 2023-2028 (K MT)
Table 68. Diabetic Retinopathy Drugs Market Opportunities & Trends in Global Market
Table 69. Diabetic Retinopathy Drugs Market Drivers in Global Market
Table 70. Diabetic Retinopathy Drugs Market Restraints in Global Market
Table 71. Diabetic Retinopathy Drugs Raw Materials
Table 72. Diabetic Retinopathy Drugs Raw Materials Suppliers in Global Market
Table 73. Typical Diabetic Retinopathy Drugs Downstream
Table 74. Diabetic Retinopathy Drugs Downstream Clients in Global Market
Table 75. Diabetic Retinopathy Drugs Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Diabetic Retinopathy Drugs Segment by Type
Figure 2. Diabetic Retinopathy Drugs Segment by Application
Figure 3. Global Diabetic Retinopathy Drugs Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Diabetic Retinopathy Drugs Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Diabetic Retinopathy Drugs Revenue, 2017-2028 (US$, Mn)
Figure 7. Diabetic Retinopathy Drugs Sales in Global Market: 2017-2028 (K MT)
Figure 8. The Top 3 and 5 Players Market Share by Diabetic Retinopathy Drugs Revenue in 2021
Figure 9. By Type - Global Diabetic Retinopathy Drugs Sales Market Share, 2017-2028
Figure 10. By Type - Global Diabetic Retinopathy Drugs Revenue Market Share, 2017-2028
Figure 11. By Type - Global Diabetic Retinopathy Drugs Price (USD/MT), 2017-2028
Figure 12. By Application - Global Diabetic Retinopathy Drugs Sales Market Share, 2017-2028
Figure 13. By Application - Global Diabetic Retinopathy Drugs Revenue Market Share, 2017-2028
Figure 14. By Application - Global Diabetic Retinopathy Drugs Price (USD/MT), 2017-2028
Figure 15. By Region - Global Diabetic Retinopathy Drugs Sales Market Share, 2017-2028
Figure 16. By Region - Global Diabetic Retinopathy Drugs Revenue Market Share, 2017-2028
Figure 17. By Country - North America Diabetic Retinopathy Drugs Revenue Market Share, 2017-2028
Figure 18. By Country - North America Diabetic Retinopathy Drugs Sales Market Share, 2017-2028
Figure 19. US Diabetic Retinopathy Drugs Revenue, (US$, Mn), 2017-2028
Figure 20. Canada Diabetic Retinopathy Drugs Revenue, (US$, Mn), 2017-2028
Figure 21. Mexico Diabetic Retinopathy Drugs Revenue, (US$, Mn), 2017-2028
Figure 22. By Country - Europe Diabetic Retinopathy Drugs Revenue Market Share, 2017-2028
Figure 23. By Country - Europe Diabetic Retinopathy Drugs Sales Market Share, 2017-2028
Figure 24. Germany Diabetic Retinopathy Drugs Revenue, (US$, Mn), 2017-2028
Figure 25. France Diabetic Retinopathy Drugs Revenue, (US$, Mn), 2017-2028
Figure 26. U.K. Diabetic Retinopathy Drugs Revenue, (US$, Mn), 2017-2028
Figure 27. Italy Diabetic Retinopathy Drugs Revenue, (US$, Mn), 2017-2028
Figure 28. Russia Diabetic Retinopathy Drugs Revenue, (US$, Mn), 2017-2028
Figure 29. Nordic Countries Diabetic Retinopathy Drugs Revenue, (US$, Mn), 2017-2028
Figure 30. Benelux Diabetic Retinopathy Drugs Revenue, (US$, Mn), 2017-2028
Figure 31. By Region - Asia Diabetic Retinopathy Drugs Revenue Market Share, 2017-2028
Figure 32. By Region - Asia Diabetic Retinopathy Drugs Sales Market Share, 2017-2028
Figure 33. China Diabetic Retinopathy Drugs Revenue, (US$, Mn), 2017-2028
Figure 34. Japan Diabetic Retinopathy Drugs Revenue, (US$, Mn), 2017-2028
Figure 35. South Korea Diabetic Retinopathy Drugs Revenue, (US$, Mn), 2017-2028
Figure 36. Southeast Asia Diabetic Retinopathy Drugs Revenue, (US$, Mn), 2017-2028
Figure 37. India Diabetic Retinopathy Drugs Revenue, (US$, Mn), 2017-2028
Figure 38. By Country - South America Diabetic Retinopathy Drugs Revenue Market Share, 2017-2028
Figure 39. By Country - South America Diabetic Retinopathy Drugs Sales Market Share, 2017-2028
Figure 40. Brazil Diabetic Retinopathy Drugs Revenue, (US$, Mn), 2017-2028
Figure 41. Argentina Diabetic Retinopathy Drugs Revenue, (US$, Mn), 2017-2028
Figure 42. By Country - Middle East & Africa Diabetic Retinopathy Drugs Revenue Market Share, 2017-2028
Figure 43. By Country - Middle East & Africa Diabetic Retinopathy Drugs Sales Market Share, 2017-2028
Figure 44. Turkey Diabetic Retinopathy Drugs Revenue, (US$, Mn), 2017-2028
Figure 45. Israel Diabetic Retinopathy Drugs Revenue, (US$, Mn), 2017-2028
Figure 46. Saudi Arabia Diabetic Retinopathy Drugs Revenue, (US$, Mn), 2017-2028
Figure 47. UAE Diabetic Retinopathy Drugs Revenue, (US$, Mn), 2017-2028
Figure 48. Global Diabetic Retinopathy Drugs Production Capacity (K MT), 2017-2028
Figure 49. The Percentage of Production Diabetic Retinopathy Drugs by Region, 2021 VS 2028
Figure 50. Diabetic Retinopathy Drugs Industry Value Chain
Figure 51. Marketing Channels
